Hattori et al. [24] demonstrated that activation of the JAK2/STAT3 signaling pathway increases the phosphorylation levels of JAK2 and STAT3, thereby reducing the expression of Bax and caspase-3, and the area of MI, while improving post-ischemic cardiac systolic function. Here, JAK2 is linked to myocardial infarction.